| Literature DB >> 25316742 |
Will Nevers, Anna Pupco, Gideon Koren, Pina Bozzo.
Abstract
QUESTION: I have a 30-year-old patient who had a kidney transplant 2 years ago. She is now planning a pregnancy. She has been treated with tacrolimus since her transplant. Will it be safe for the fetus if she continues to take it during the pregnancy or should she switch to a different antirejection medication? ANSWER: If your patient is stable while taking tacrolimus, there is no reason to switch. The current available information does not suggest that tacrolimus increases the risk of major congenital malformations above the baseline risk in the general population. Premature birth and low birth weight are often reported in this population; however, these effects are frequently reported in pregnant transplant patients treated with other immunosuppressant agents and probably reflect the effects of the maternal condition. As there are some reports of hyperkalemia and renal impairment in infants exposed to tacrolimus in utero, kidney function and electrolytes should be monitored in exposed neonates. Copyright© the College of Family Physicians of Canada.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25316742 PMCID: PMC4196812
Source DB: PubMed Journal: Can Fam Physician ISSN: 0008-350X Impact factor: 3.275